Sentence examples for deaths hazard from inspiring English sources

Medically certified absences were associated with mortality from suicide (ICD-9 code E95, ICD-10 codes X60-X84) or external cause of undetermined intent (ICD-9 E98, ICD-10 Y10-Y34) (six deaths, hazard ratio 6.9, 1.2 to 39.1).

The mean duration of admissions related to pneumonia was similar for both groups, but mortality related to pneumonia was higher in the fluticasone/salmeterol group (97 deaths) than in the budesonide/formoterol group (52 deaths) (hazard ratio 1.76, 1.22 to 2.53; P=0.003).

Power was calculated as a function of the number of events (NE), in this case deaths, hazard ratio (HR) and the significance level as derived by Schoenfeld [ 23]: z p o w e r = N E × log (H R ) 2 - z 1 - α 2 The probability of finding a specific HR given a certain NE and using a significance level of α is calculated from Zpower.

Cox proportional-hazards model estimated the death risk (hazard ratio (HR)) for various prognostic factors.

Results: Advanced and moderate CRI independently predicted death (hazard ratio, 1.06; 95% confidence interval [CI], 1.01 to 1.12; and hazard ratio, 1.23; 95% CI, 1.18 to 1.29).

Severe anemia (hemoglobin level < 9.0 g/dL [<90 g/L]) also was an independent risk factor for death (hazard ratio, 1.38; 95% CI, 1.18 to 1.61).

In comparison to OHCA, IHCA was associated with a lower risk of death (hazard ratio [HR] 0.90, 95% confidence interval [CI] 0.82-0.99, p = 0.02), while risk of death for ICU-CA was similar (HR 1.09, 95% CI 1.00-1.19, p = 0.06).

No significant differences were observed between weight change and any in-hospital or follow-up events (days well: hazard ratio 0.995, 95% confidence interval 0.975 to 1.016; 180-day death: hazard ratio 1.012, 95% confidence interval 0.969 to 1.057; death or rehospitalization at 180 days: hazard ratio 1.014, 95% confidence interval 0.990 to 1.038).

The hazard rate was 4.04 (95% CI: 2.07 7.91), meaning that death hazard for a mouse in the non-treated AKI group was 4.04 times greater than for a mouse in the VLP-treated group.

Accordingly, we substituted the death hazard for GIST patients following treatment with imatinib mesylate with the death hazard function of the general population times 1.08 in our calculations.

Importantly, the death hazard was evident even in the lowest tertile of use.